Since 2020, the government has covered COVID-19 vaccine costs, but pharmaceutical companies are preparing for the inevitable switch to selling the vaccines commercially once federal funds run dry — which could happen in early 2023.
Under its first contract, the government paid Pfizer $19.50 per dose, and for the most recent deal this summer, that number rose to about $30.50 per dose.
In late October, a Pfizer spokesperson said the company was considering selling its COVID-19 vaccine in single doses instead of multi-dose vials, which is part of the reason for the price bump.
The drugmaker is still negotiating the vaccine’s commercial price with insurance companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
